Avricore Health Inc. AVCRF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 73.68% | 34.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 73.68% | 34.58% | |||
| Cost of Revenue | 42.49% | 32.19% | |||
| Gross Profit | 117.46% | -21.15% | |||
| SG&A Expenses | 1.29% | -31.41% | |||
| Depreciation & Amortization | -- | 358.33% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.53% | -22.93% | |||
| Operating Income | 4.83% | 28.69% | |||
| Income Before Tax | -33.13% | 77.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -33.13% | 77.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.13% | 77.92% | |||
| EBIT | 4.83% | 28.69% | |||
| EBITDA | 2.06% | 26.69% | |||
| EPS Basic | -26.67% | 77.61% | |||
| Normalized Basic EPS | -33.33% | 40.00% | |||
| EPS Diluted | -26.67% | 77.61% | |||
| Normalized Diluted EPS | -33.33% | 40.00% | |||
| Average Basic Shares Outstanding | 3.54% | 0.00% | |||
| Average Diluted Shares Outstanding | 3.54% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||